Journal Title：Pharmacogenomics & Personalized Medicine

Pharmacogenomics and Personalized Medicine is an international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.

In particular, emphasis will be given to:

Genomic and proteomic profiling

Genetics and drug metabolism

Targeted drug identification and discovery

Optimizing drug selection & dosage based on patient's genetic profile

Drug related morbidity & mortality intervention

Advanced disease screening and targeted therapeutic intervention

Genetic based vaccine development

Patient satisfaction and preference

Health economic evaluations

Practical and organizational issues in the development and implementation of personalized medicine programs.

藥物基因組學(xué)和個性化醫(yī)療是一本國際性的、同行評審的、開放獲取的期刊，描述了基因型對藥理學(xué)的影響，從而開發(fā)個性化治療方案和個性化藥物選擇，以提高安全性、有效性和可持續(xù)性。

特別是，將重點關(guān)注：

基因組和蛋白質(zhì)組學(xué)分析

遺傳學(xué)和藥物代謝

靶向藥物識別和發(fā)現(xiàn)

根據(jù)患者的基因特征優(yōu)化藥物選擇和劑量

藥物相關(guān)發(fā)病率和死亡率干預(yù)

高級疾病篩查和有針對性的治療干預(yù)

基于基因的疫苗開發(fā)

患者滿意度和偏好

健康經(jīng)濟(jì)評估

個性化醫(yī)療計劃的制定和實施中的實際和組織問題。

Pharmacogenomics & Personalized Medicine由Dove Medical Press出版商出版，收稿方向涵蓋Biochemistry, Genetics and Molecular Biology - Molecular Medicine全領(lǐng)域，此期刊水平偏中等偏靠后，在所屬細(xì)分領(lǐng)域中專業(yè)影響力一般，過審相對較易，如果您文章質(zhì)量佳，選擇此期刊，發(fā)表機(jī)率較高。平均審稿速度 16 Weeks ，影響因子指數(shù)1.8，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。